Work Productivity in Hyperventilation Syndrome

Hyperventilation Syndrome Clinical Trial

— WHY  

Official title:

Work Productivity in Hyperventilation Syndrome

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03292523
• Other study ID #: 2016_68
• Secondary ID: 2017-A01542-51
• Status: Completed
• Start date: February 6, 2018
• Est. completion date: February 23, 2021

Study information

• Verified date: April 2022
• Source: University Hospital, Lille
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Hyperventilation syndrome is associated with impaired quality of life. The aim of the study is to assess the relationship between work productivity, including absenteeism and presenteeism, and the severity of hyperventilation syndrome

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: February 23, 2021
• Est. primary completion date: February 23, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Holders of employment contracts for at least 8 days

• Diagnosis of hyperventilation syndrome confirmed by:

Compatible symptoms and at least two symptoms reproduced by the hyperventilation challenge test: Nijmegen's score> 23 ; Demonstration of alveolar hyperventilation ( Either on rest blood and / or at rest (PaCO2 at rest <36 mmHg and D (A-a) O2 normal; Either during the HV test (increased recovery time of the basic PETCO2 after voluntary hyperventilation (greater than 5 minutes)

Exclusion Criteria:

• Existence of another chronic pulmonary disease (asthma, bronchial dilation, COPD, diffuse interstitial pneumonia, neuromuscular pathology ...) or cardiac (rhythm disorder, ischemic heart disease ...) which can participate in dyspnea

• Psychiatric illness / psychotropic treatment

• Pregnancy

• Patient already included in a clinical research protocol involving new therapeutics may not be included in this protocol

• Specific physiotherapy or previous training

Related Conditions & MeSH terms

• Hyperventilation
• Hyperventilation Syndrome
• Syndrome

Intervention

Other:
• questionnaire
Work Productivity and Activity Impairment (WPAI) Multidimensional Dyspnea Profile (MDP) Baseline Dyspnea Index (BDI), MOS-SF36, Hospital Anxiety Depression (HAD) Cognitive Failure Questionnaire (CFQ).

Locations

Country	Name	City	State
France	Hôpital Calmette,CHU	Lille

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Lille

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Association between the WPAI score and the Nijmegen score		At the time of diagnosis (Baseline)
Secondary	Association between the WPAI score and dyspnea scales		At the time of diagnosis (Baseline)
Secondary	Association between the WPAI score and quality of life scores		At the time of diagnosis (Baseline)
Secondary	Association between the WPAI score and PaCO2		At the time of diagnosis (Baseline)
Secondary	Association between the WPAI score and the Cognitive Failure Questionnaire score		At the time of diagnosis (Baseline)